Allopurinol, a drug normally prescribed for gout, is being used to test for
tumours in patients at high risk of developing cancer due to genetic or
environmental factors. Developed by researchers at Johns Hopkins University in
Baltimore, Maryland, the test uses allopurinol to temporarily slow DNA
production in cancer cells, causing some components of DNA—called
pyrimidines—to accumulate in the blood. These can be detected in the
patient’s urine.
More from New ¾«¶«´«Ã½
Explore the latest news, articles and features
Life
Himalayan wolf-dog hybrids emerge as a threat to wolves and people
News
Environment
First test of CO2 removal with green sand finds no harm to marine life
News
Space
SpaceX is about to launch tallest and most powerful rocket in history
News
Environment
Cleaning up air pollution could weaken vital AMOC ocean current
News
Popular articles
Trending New ¾«¶«´«Ã½ articles
1
Why autism pioneer Uta Frith wants to dismantle the spectrum
2
A new tectonic plate boundary could be forming in southern Africa
3
CAR T-cell therapy bolstered by stiffening up cancer cells first
4
Himalayan wolf-dog hybrids emerge as a threat to wolves and people
5
Rebooting stem cells builds aged muscles and assists injury recovery
6
Vocal fry is more common in men, actually, find scientists
7
First test of CO2 removal with green sand finds no harm to marine life
8
Neanderthals treated a dental cavity by drilling into the tooth
9
3 things you need to know about quantum computers, from an expert
10
Where did the laws of physics come from? I think I've found the answer
